Efficacy of Hydroxychloroquine and Tocilizumab in Patients With COVID-19: Single-Center Retrospective Chart Review.

J Med Internet Res · 2020 · PMC7470234 · PMID 32784192

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

By demonstrating a nonsignificant trend in all the above-mentioned outcomes, we recommend against the routine use of HCQ and TCZ in patients with COVID-19.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.